Mimedx (MDXG) Free Cash Flow (2011 - 2026)

Mimedx (MDXG) has 16 years of Free Cash Flow data on file, last reported at $1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow fell 73.41% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $69.4 million (up 5.84% YoY), and the FY2025 full-year result was $73.0 million, up 11.5% from the prior year.
• Free Cash Flow retreated to $1.3 million in Q1 2026, from $24.7 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $29.1 million in Q3 2025 to a low of -$10.3 million in Q1 2022.
• A 5-year average of $9.1 million and a median of $4.9 million in 2025 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow plunged 383.5% in 2022 and jumped 2206.71% in 2024, its largest moves.
• Tracing MDXG's Free Cash Flow over 5 years: stood at $3.6 million in 2022, then sank by 124.21% to -$879000.0 in 2023, then jumped by 2206.71% to $18.5 million in 2024, then soared by 33.23% to $24.7 million in 2025, then plunged by 94.69% to $1.3 million in 2026.
• Business Quant data shows MDXG's Free Cash Flow at $1.3 million in Q1 2026, $24.7 million in Q4 2025, and $29.1 million in Q3 2025.